Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Advances in hepatitis C treatment. Why aren’t they being used?

Nezam H. Afdhal, MD
Conditions
February 7, 2015
234 Shares
Share
Tweet
Share

The really incredible advances in the treatment of hepatitis C bring to life several relevant questions as we move forward into 2015. First, who should be treating hepatitis C patients (primary care providers, gastroenterologists, infectious disease specialists)? Second, can we really afford to use these new treatments? I recently discussed this topic with my GI and hepatology colleagues in AGA Perspectives, the bi-monthly opinion magazine of the American Gastroenterological Association, but it’s time we extend this conversation outside of our community.

First, let’s consider sofosbuvir and ledipasvir, a single fixed-dose combination pill with over a 95 percent cure rate that was approved by the FDA for genotype 1 HCV in October 2014. Like other all-oral direct-acting antivirals, the simplicity, safety and effectiveness of this treatment should enable almost any physician with an interest in HCV to treat a patient. The pretreatment workup consists of simple blood tests, genotyping and determination of viral load and staging of disease with non-invasive serum tests such as FibroTest or a FibroScan to determine the presence of advanced fibrosis or cirrhosis. Patients at risk of advanced liver disease should undergo specialty evaluation by either a specialist infection disease (ID) physician or gastroenterologist, while patients who pass these tests can likely be treated in a primary care setting.

Unfortunately, although I truly believe that hepatitis C can be easily treated within the community including by internists and family physicians, the reality is that issues associated with both the cost of treatment and access to therapy have made this extremely difficult. Hepatitis C medications cost almost $100,000 or more for a full course of treatment and thus represent a significant burden on the health care system. If, over the course of the next 10 years, we treat 1 million patients — which is necessary if we are to impact the natural history of disease — then the cost to the health care system would be almost $100 billion.

This high cost of therapy has resulted in prioritization of care with restricted access for some patients. Currently, the majority of third-party payers and state Medicaid have limited access to those patients with advanced fibrosis or cirrhosis. And recently, the news has been about exclusivity deals between pharmacies and health plans and the makers of hepatitis C treatments.

In our practice, we have found that the current restrictions require almost one or two full-time personnel to devote continuous effort to help patients obtain treatment. In smaller GI or ID practices, this would create both unnecessary expense and significant effort. It is hard to imagine that an average internal medicine or family practice would have the resources to devote the time and personnel needed to obtain prior approval and authorization for treatment of any significant number of hepatitis C patients. In addition, certain state Medicaid plans — such as New York — have suggested that treatment only be provided by physicians with documented and proven experience in managing HCV patients.

In my experience, this potential rationing of health care to only those with advanced disease makes little clinical or pharmacoeconomic sense. Treatment duration can be shortened in patients that do not have cirrhosis resulting in a lower cost per sustained virologic response. In addition, these patients have reported equal improvements in a variety of physical, emotional and health-related outcomes as is reported for patients with more advanced disease.

Finally, it is ironic that here we are with the ability to essentially eradicate hepatitis C from the U.S. population within the next decade using simple, safe and highly effective therapies, and yet we appear to lack both the economic, societal and political wherewithal to make this a reality. The conversations must continue: How can we make this incredible opportunity a reality for our patients?

Nezam H. Afdhal is director of hepatology, Beth Israel Deaconess Medical Center, Boston, MA.

Prev

Touching a life on the other side of the world

February 6, 2015 Kevin 0
…
Next

You may not want this vaccine. But after watching this, you may want to think again.

February 7, 2015 Kevin 0
…

Tagged as: Gastroenterology, Medications

Post navigation

< Previous Post
Touching a life on the other side of the world
Next Post >
You may not want this vaccine. But after watching this, you may want to think again.

More in Conditions

  • The psychoanalytic hammer: lessons in listening and patient-centered care

    Greg Smith, MD
  • 5 essential tips to help men prevent prostate cancer

    Kevin Jones, MD
  • Changing the pediatric care landscape: Integrating behavioral and mental health care

    Hilary M. Bowers, MD
  • Unlocking the secret to successful weight loss: Curiosity is the key

    Franchell Hamilton, MD
  • The teacher who changed my life through reading

    Raymond Abbott
  • Revaluating mental health assessments: It’s not just the patient you should consider

    Tomi Mitchell, MD
  • Most Popular

  • Past Week

    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • From physician to patient: one doctor’s journey to finding purpose after a devastating injury

      Stephanie Pearson, MD | Physician
    • Breaking the stigma: Addressing the struggles of physicians

      Jean Antonucci, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The Titanic sinking: a metaphor for the impending collapse of medicine

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD & Shreekant Vasudhev, MD | Physician
  • Recent Posts

    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
    • What I think it means to be a medical student in the wake of AI

      Jackson J. McCue | Tech
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • From rural communities to underserved populations: How telemedicine is bridging health care gaps

      Harvey Castro, MD, MBA | Physician
    • 5 essential tips to help men prevent prostate cancer

      Kevin Jones, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • Sam Neill's Rare Lymphoma
  • Day in the Life of a Doctor: Treating a Patient With Septic Shock
  • Paxlovid May Lower Long COVID Risk, VA Study Suggests
  • Digital Inhalers May Improve Uncontrolled Asthma Management
  • Another Win for Zolbetuximab in Advanced Gastric/GEJ Cancer

Meeting Coverage

  • Switch to IL-23 Blocker Yields Deep Responses in Recalcitrant Plaque Psoriasis
  • Biomarkers of Response With Enfortumab Vedotin in Advanced Urothelial Cancer
  • At-Home Topical Therapy for Molluscum Contagiosum Gets High Marks
  • Outlook for Itchy Prurigo Nodularis Continues to Improve With IL-31 Antagonist
  • AAAAI President Shares Highlights From the 2023 Meeting
  • Most Popular

  • Past Week

    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The real cause of America’s opioid crisis: Doctors are not to blame

      Richard A. Lawhern, PhD | Meds
    • The struggle to fill emergency medicine residency spots: Exploring the factors behind the unfilled match

      Katrina Gipson, MD, MPH | Physician
    • Healing the damaged nurse-physician dynamic

      Angel J. Mena, MD and Ali Morin, MSN, RN | Policy
    • From physician to patient: one doctor’s journey to finding purpose after a devastating injury

      Stephanie Pearson, MD | Physician
    • Breaking the stigma: Addressing the struggles of physicians

      Jean Antonucci, MD | Physician
  • Past 6 Months

    • The hidden dangers of the Nebraska Heartbeat Act

      Meghan Sheehan, MD | Policy
    • The vital importance of climate change education in medical schools

      Helen Kim, MD | Policy
    • The fight for reproductive health: Why medication abortion matters

      Catherine Hennessey, MD | Physician
    • Resetting the doctor-patient relationship: Navigating the challenges of modern primary care

      Jeffrey H. Millstein, MD | Physician
    • Nobody wants this job. Should physicians stick around?

      Katie Klingberg, MD | Physician
    • The Titanic sinking: a metaphor for the impending collapse of medicine

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD & Shreekant Vasudhev, MD | Physician
  • Recent Posts

    • Revolutionizing COPD management with virtual care solutions [PODCAST]

      The Podcast by KevinMD | Podcast
    • What I think it means to be a medical student in the wake of AI

      Jackson J. McCue | Tech
    • It’s time for C-suite to contract directly with physicians for part-time work

      Aaron Morgenstein, MD & Corinne Sundar Rao, MD | Physician
    • The psychoanalytic hammer: lessons in listening and patient-centered care

      Greg Smith, MD | Conditions
    • From rural communities to underserved populations: How telemedicine is bridging health care gaps

      Harvey Castro, MD, MBA | Physician
    • 5 essential tips to help men prevent prostate cancer

      Kevin Jones, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today iMedicalApps
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...